Breakthrough AI-powered genome editing tools now enable full chromosome manipulation—ushering in a new era of gene therapy and bioethics.

The FDA's approval of the first CRISPR-Cas9–based gene therapy marked a major milestone in biomedicine, validating genome ...

A vital question facing generative AI and AI makers is whether AI is performing therapy services. If so, they can be ...

DNA replication is a fundamental biological process that enables the accurate duplication of an organism’s genetic material. This intricate mechanism ensures that each new cell receives a complete set ...

There's a fresh push to edit the genes of human embryos to prevent diseases and enhance characteristics that parents value.

The primary safety risks associated with gene therapy include immune reactions and off-target effects in unintended organs, ...

Targeted rewriting of the epigenome promises to overcome several challenges in direct gene editing in patient therapies.

Researchers in gastroenterology and hepatology at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), have ...

Cas9 in germline editing presents opportunities for genetic disease correction, alongside risks of off-target effects and ...

CRISPR gene editing shows potential for treating genetic diseases. Explore how it may impact Down syndrome treatment and ...

If drug developers are allowed to skip this step, it will mean that, in the near future, the first living body a new drug is ever tested in will be a human.